Matches in Wikidata for { <http://www.wikidata.org/entity/Q65383171> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q65383171 description "clinical trial" @default.
- Q65383171 description "ensayu clínicu" @default.
- Q65383171 description "klinisch onderzoek" @default.
- Q65383171 description "клінічне випробування" @default.
- Q65383171 name "Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)" @default.
- Q65383171 name "Comparison of Sugammadex" @default.
- Q65383171 type Item @default.
- Q65383171 label "Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)" @default.
- Q65383171 label "Comparison of Sugammadex" @default.
- Q65383171 prefLabel "Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)" @default.
- Q65383171 prefLabel "Comparison of Sugammadex" @default.
- Q65383171 P1132 Q65383171-9B29F5E9-64ED-4A1C-A212-0CBB4AF90421 @default.
- Q65383171 P1476 Q65383171-B244E548-F832-4EB8-9236-3024BB7C6013 @default.
- Q65383171 P2899 Q65383171-CD307F0F-2A1A-4AB0-830C-36E2DF8D5C43 @default.
- Q65383171 P3098 Q65383171-2B94AEB9-0AE7-4FF2-9AC9-00DAEC463884 @default.
- Q65383171 P31 Q65383171-C45B87BA-095E-453D-8F2E-8FE3D4B84B8C @default.
- Q65383171 P4844 Q65383171-9B4EA717-6E91-4E77-AFD7-1C9EF5FE0C32 @default.
- Q65383171 P4844 Q65383171-C633A99E-2995-491F-BCEC-07E01F916A7E @default.
- Q65383171 P580 Q65383171-E14FC010-5DBE-4EC5-8E2F-021B4604AA07 @default.
- Q65383171 P582 Q65383171-9945D036-0F42-44C9-896F-09CAFDE24F04 @default.
- Q65383171 P6099 Q65383171-BB94367B-49EB-4BEC-8A66-AB43712C14DA @default.
- Q65383171 P8363 Q65383171-DA8BFE05-D9E2-435A-AD0C-7A487F089D30 @default.
- Q65383171 P1132 "+182" @default.
- Q65383171 P1476 "A Multicenter, Randomized, Parallel Group Comparative, Active-Controlled, Safety-assessor Blinded. Phase IIIa, Pivotal Trial in Adult Subjects Comparing Org 25969 With Neostigmine as Reversal Agent of a Neuromuscular Block Induced by Maintenance Dosing of Rocuronium or Vecuronium at 1-2 PTCs" @default.
- Q65383171 P2899 "+18" @default.
- Q65383171 P3098 "NCT00473694" @default.
- Q65383171 P31 Q30612 @default.
- Q65383171 P4844 Q27108523 @default.
- Q65383171 P4844 Q411917 @default.
- Q65383171 P580 "2005-11-28T00:00:00Z" @default.
- Q65383171 P582 "2006-11-06T00:00:00Z" @default.
- Q65383171 P6099 Q42824827 @default.
- Q65383171 P8363 Q78089383 @default.